{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T19:22:20Z","timestamp":1746645740759,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T00:00:00Z","timestamp":1714953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T00:00:00Z","timestamp":1714953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014584","name":"Universit\u00e4tsmedizin der Johannes Gutenberg-Universit\u00e4t Mainz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014584","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Patients with intracranial gliomas frequently seek for complementary and alternative medicine (CAM), in addition to guideline-directed therapy. In this study, we therefore assessed patients\u2019 information needs regarding treatment and support, and evaluated their attitudes toward experimental trials and alternative therapies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A prospective, cross-sectional, descriptive survey was conducted in our center. We developed an interview focusing on how patients obtain further information about therapy and the use of alternative\/complementary therapies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 102 patients participated in the survey. 50% (<jats:italic>n<\/jats:italic>\u2009=\u200951) of patients reported that they had not attempted any additional therapies. When patients attempted self-therapy, it was most commonly in the areas of nutrition (25%, <jats:italic>n<\/jats:italic>\u2009=\u200926) and dietary supplements (17%, <jats:italic>n<\/jats:italic>\u2009=\u200917). Alternative or complementary therapies were used by 14% (<jats:italic>n<\/jats:italic>\u2009=\u200914) of the patients. Younger age (Odds ratio (OR) 0.96 (95% Confidence interval (CI) 0.92\u20130.99, <jats:italic>p<\/jats:italic>\u2009=\u20090.012) and tumor entity (OR 5.01 (95% CI 1.66\u201315.11, <jats:italic>p<\/jats:italic>\u2009=\u20090.004) for grade 4 vs. 3 tumors and OR 7.22 (95% CI 1.99\u201326.28) for grade 4 vs. other tumors <jats:italic>p<\/jats:italic>\u2009=\u20090.003) were significantly associated with a greater interest in CAM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Interest in complementary and alternative medicine, as well as nutrition and dietary supplements is high (51%) among glioma patients, and significantly higher among younger patients and those with a worse diagnosis (WHO grade 4). A comprehensive approach to information, including paramedical topics, is needed to provide optimal patient counseling and care for glioma patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11060-024-04696-1","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T09:01:54Z","timestamp":1714986114000},"page":"507-513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Use of complementary therapies and supportive measures of patients with intracranial gliomas\u2014a prospective evaluation in an outpatient clinic"],"prefix":"10.1007","volume":"168","author":[{"given":"Malte","family":"Ottenhausen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjam","family":"Renovanz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabell","family":"Bartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Poplawski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darius","family":"Kalasauskas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Krenzlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naureen","family":"Keric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Ringel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,6]]},"reference":[{"key":"4696_CR1","doi-asserted-by":"publisher","unstructured":"van den Bent MJ, Geurts M, French PJ, Smits M, Capper D, Bromberg JEC, Chang SM (2023) Primary brain tumours in adults. Lancet. 28;402(10412):1564\u20131579. https:\/\/doi.org\/10.1016\/S0140-6736(23)01054-1","DOI":"10.1016\/S0140-6736(23)01054-1"},{"issue":"3","key":"4696_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s11060-017-2607-5","volume":"135","author":"BK Rasmussen","year":"2017","unstructured":"Rasmussen BK, Hansen S, Laursen RJ, Kosteljanetz M, Schultz H, N\u00f8rg\u00e5rd BM, Guldberg R, Gradel KO (2017) Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I-IV in the the Danish Neuro-Oncology Registry. J Neurooncol 135(3):571\u2013579. https:\/\/doi.org\/10.1007\/s11060-017-2607-5","journal-title":"J Neurooncol"},{"issue":"10","key":"4696_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"issue":"9","key":"4696_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11864-016-0422-4","volume":"17","author":"A Tosoni","year":"2016","unstructured":"Tosoni A, Franceschi E, Poggi R, Brandes AA (2016) Relapsed glioblastoma: treatment strategies for initial and subsequent recurrences. Curr Treat Options Oncol 17(9):49. https:\/\/doi.org\/10.1007\/s11864-016-0422-4","journal-title":"Curr Treat Options Oncol"},{"key":"4696_CR5","doi-asserted-by":"publisher","unstructured":"Pfaff E, Kessler T, Balasubramanian GP, Berberich A, Schrimpf D, Wick A, Debus J, Unterberg A, Bendszus M, Herold-Mende C, Capper D, Schenkel I, Eisenmenger A, Dettmer S, Brors B, Platten M, Pfister SM, von Deimling A, Jones DTW, Wick W, Sahm F (2018) Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation-the NCT Neuro Master Match (N2M2) pilot study. Neuro Oncol. 18;20(6):826\u2013837. https:\/\/doi.org\/10.1093\/neuonc\/nox216","DOI":"10.1093\/neuonc\/nox216"},{"issue":"7738","key":"4696_CR6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41586-018-0810-y","volume":"565","author":"N ilf","year":"2019","unstructured":"ilf N, Kuttruff-Coqui S, Frenzel K, Bukur V, Stevanovi\u0107 S, Gouttefangeas C, Platten M, Tabatabai G, Dutoit V, van der Burg SH, Thor Straten P, Mart\u00ednez-Ricarte F, Ponsati B, Okada H, Lassen U, Admon A, Ottensmeier CH, Ulges A, Kreiter S, von Deimling A, Skardelly M, Migliorini D, Kroep JR, Idorn M, Rodon J, Pir\u00f3 J, Poulsen HS, Shraibman B, McCann K, Mendrzyk R, L\u00f6wer M, Stieglbauer M, Britten CM, Capper D, Welters MJP, Sahuquillo J, Kiesel K, Derhovanessian E, Rusch E, Bunse L, Song C, Heesch S, Wagner C, Kemmer-Br\u00fcck A, Ludwig J, Castle JC, Schoor O, Tadmor AD, Green E, Fritsche J, Meyer M, Pawlowski N, Dorner S, Hoffgaard F, R\u00f6ssler B, Maurer D, Weinschenk T, Reinhardt C, Huber C, Rammensee HG, Singh-Jasuja H, Sahin U, Dietrich PY, Wick W (2019) Actively personalized vaccination trial for newly diagnosed glioblastoma. Nature 565(7738):240\u2013245. https:\/\/doi.org\/10.1038\/s41586-018-0810-y","journal-title":"Nature"},{"key":"4696_CR7","doi-asserted-by":"publisher","unstructured":"Yang Y, Brown MC, Zhang G, Stevenson K, Mohme M, Kornahrens R, Bigner DD, Ashley DM, L\u00f3pez GY, Gromeier M (2023) Polio virotherapy targets the malignant glioma myeloid infiltrate with diffuse microglia activation engulfing the CNS. Neuro Oncol. 5;25(9):1631\u20131643. https:\/\/doi.org\/10.1093\/neuonc\/noad052","DOI":"10.1093\/neuonc\/noad052"},{"key":"4696_CR8","doi-asserted-by":"publisher","unstructured":"Renovanz M, Hickmann AK, Coburger J, Kohlmann K, Janko M, Reuter AK, Keric N, Nadji-Ohl M, K\u00f6nig J, Singer S, Giese A, Hechtner M (2018) Assessing psychological and supportive care needs in glioma patients - feasibility study on the use of the supportive care needs Survey short form (SCNS-SF34-G) and the supportive care needs Survey Screening Tool (SCNS-ST9) in clinical practice. Eur J Cancer Care (Engl) 27(1). https:\/\/doi.org\/10.1111\/ecc.12598","DOI":"10.1111\/ecc.12598"},{"issue":"4","key":"4696_CR9","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/neuonc\/nor229","volume":"14","author":"E Ford","year":"2012","unstructured":"Ford E, Catt S, Chalmers A, Fallowfield L (2012) Systematic review of supportive care needs in patients with primary malignant brain tumors. Neuro Oncol 14(4):392\u2013404. https:\/\/doi.org\/10.1093\/neuonc\/nor229","journal-title":"Neuro Oncol"},{"issue":"12","key":"4696_CR10","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1007\/s00701-013-1884-9","volume":"155","author":"M Renovanz","year":"2013","unstructured":"Renovanz M, Gutenberg A, Haug M, Strittmatter E, Mazur J, Nadji-Ohl M, Giese A, Hopf N (2013) Postsurgical screening for psychosocial disorders in neurooncological patients. Acta Neurochir (Wien) 155(12):2255\u20132261. https:\/\/doi.org\/10.1007\/s00701-013-1884-9","journal-title":"Acta Neurochir (Wien)"},{"issue":"2","key":"4696_CR11","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/neuonc\/nou127","volume":"17","author":"PO Valko","year":"2015","unstructured":"Valko PO, Siddique A, Linsenmeier C, Zaugg K, Held U, Hofer S (2015) Prevalence and predictors of fatigue in glioblastoma: a prospective study. Neuro Oncol 17(2):274\u2013281. https:\/\/doi.org\/10.1093\/neuonc\/nou127","journal-title":"Neuro Oncol"},{"issue":"2","key":"4696_CR12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1227\/01.neu.0000103450.94724.a2","volume":"54","author":"NS Litofsky","year":"2004","unstructured":"Litofsky NS, Farace E, Anderson F Jr, Meyers CA, Huang W, Laws ER Jr, Glioma Outcomes Project Investigators (2004) Depression in patients with high-grade glioma: results of the Glioma outcomes Project. Neurosurgery 54(2):358\u2013366 discussion 366-7. https:\/\/doi.org\/10.1227\/01.neu.0000103450.94724.a2","journal-title":"Neurosurgery"},{"issue":"3","key":"4696_CR13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11060-013-1069-7","volume":"112","author":"B Flechl","year":"2013","unstructured":"Flechl B, Ackerl M, Sax C, Oberndorfer S, Calabek B, Sizoo E, Reijneveld J, Crevenna R, Keilani M, Gaiger A, Dieckmann K, Preusser M, Taphoorn MJ, Marosi C (2013) The caregivers\u2019 perspective on the end-of-life phase of glioblastoma patients. J Neurooncol 112(3):403\u2013411. https:\/\/doi.org\/10.1007\/s11060-013-1069-7","journal-title":"J Neurooncol"},{"issue":"1","key":"4696_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/nop\/npt004","volume":"1","author":"T Walbert","year":"2014","unstructured":"Walbert T (2014) Integration of palliative care into the neuro-oncology practice: patterns in the United States. Neurooncol Pract 1(1):3\u20137. https:\/\/doi.org\/10.1093\/nop\/npt004","journal-title":"Neurooncol Pract"},{"issue":"1","key":"4696_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11060-014-1362-0","volume":"117","author":"CE Champ","year":"2014","unstructured":"Champ CE, Palmer JD, Volek JS, Werner-Wasik M, Andrews DW, Evans JJ, Glass J, Kim L, Shi W (2014) Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme. J Neurooncol 117(1):125\u2013131. https:\/\/doi.org\/10.1007\/s11060-014-1362-0","journal-title":"J Neurooncol"},{"key":"4696_CR16","doi-asserted-by":"publisher","unstructured":"Trogrli\u0107 I, Trogrli\u0107 D, Trogrli\u0107 D, Trogrli\u0107 AK (2018) Treatment of glioblastoma with herbal medicines. World J Surg Oncol. 13;16(1):28. https:\/\/doi.org\/10.1186\/s12957-018-1329-2","DOI":"10.1186\/s12957-018-1329-2"},{"issue":"3","key":"4696_CR17","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.21873\/anticanres.11438","volume":"37","author":"J Onken","year":"2017","unstructured":"Onken J, Friesen C, Vajkoczy P, Misch M (2017) Safety and Tolerance of D,L-Methadone in Combination with Chemotherapy in patients with Glioma. Anticancer Res 37(3):1227\u20131235. https:\/\/doi.org\/10.21873\/anticanres.11438","journal-title":"Anticancer Res"},{"key":"4696_CR18","unstructured":"NCCIH. Complementary, alternative, or integrative health: What\u2019s in a name. (2015) [Internet]. URL: https:\/\/nccih.nih.gov\/health\/whatiscam"},{"key":"4696_CR19","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1007\/s00520-020-05354-8","volume":"11","author":"M Renovanz","year":"2020","unstructured":"Renovanz M, Hickmann AK, Nadji-Ohl M, Keric N, Weimann E, Wirtz CR, Singer S, Ringel F, Coburger J (2020) Health-related quality of life and distress in elderly vs. younger patients with high-grade glioma-results of a multicenter study. Support Care Cancer 11:5165\u20135175. https:\/\/doi.org\/10.1007\/s00520-020-05354-8","journal-title":"Support Care Cancer"},{"key":"4696_CR20","doi-asserted-by":"publisher","unstructured":"Renovanz M, Hechtner M, Janko M, Kohlmann K, Coburger J, Nadji-Ohl M, K\u00f6nig J, Ringel F, Singer S, Hickmann AK Factors associated with supportive care needs in glioma patients in the neuro-oncological outpatient setting (2017). J Neurooncol 133(3):653\u2013662. https:\/\/doi.org\/10.1007\/s11060-017-2484-y","DOI":"10.1007\/s11060-017-2484-y"},{"key":"4696_CR21","doi-asserted-by":"publisher","unstructured":"Heese O, Schmidt M, Nickel S, Berger H, Goldbrunner R, Tonn JC, B\u00e4hr O, Steinbach JP, Simon M, Schramm J, Krex D, Schackert G, Reithmeier T, Nikkhah G, L\u00f6ffler M, Weller M, Westphal M, German Glioma Network (2010) Complementary therapy use in patients with glioma: an observational study. Neurology. 14;75(24):2229-35. https:\/\/doi.org\/10.1212\/WNL.0b013e31820202c6","DOI":"10.1212\/WNL.0b013e31820202c6"},{"issue":"3","key":"4696_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s11060-019-03315-8","volume":"145","author":"E Le Rhun","year":"2019","unstructured":"Le Rhun E, Devos P, Bourg V, Darlix A, Lorgis V, Ahle G, Boone M, Taillandier L, Curtit E, Gras L, Lebrun Frenay C, Gramatzki D, Ramirez C, Simon N, Weller M (2019) Complementary and alternative medicine use in glioma patients in France. J Neurooncol 145(3):487\u2013499. https:\/\/doi.org\/10.1007\/s11060-019-03315-8","journal-title":"J Neurooncol"},{"issue":"3","key":"4696_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/1534735411423920","volume":"11","author":"M Horneber","year":"2012","unstructured":"Horneber M, Bueschel G, Dennert G, Less D, Ritter E, Zwahlen M (2012) How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther 11(3):187\u2013203. https:\/\/doi.org\/10.1177\/1534735411423920","journal-title":"Integr Cancer Ther"},{"issue":"3","key":"4696_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/nop\/npy035","volume":"6","author":"G Eisele","year":"2019","unstructured":"Eisele G, Roelcke U, Conen K, Huber F, Weiss T, Hofer S, Heese O, Westphal M, Hertler C, Roth P, Weller M (2019) Complementary and alternative medicine use by glioma patients in Switzerland. Neurooncol Pract 6(3):237\u2013244. https:\/\/doi.org\/10.1093\/nop\/npy035","journal-title":"Neurooncol Pract"},{"issue":"3","key":"4696_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/nop\/npv008","volume":"2","author":"BH Mulpur","year":"2015","unstructured":"Mulpur BH, Nabors LB, Thompson RC, Olson JJ, LaRocca RV, Thompson Z, Egan KM (2015) Complementary therapy and survival in glioblastoma. Neurooncol Pract 2(3):122\u2013126. https:\/\/doi.org\/10.1093\/nop\/npv008","journal-title":"Neurooncol Pract"},{"issue":"2","key":"4696_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.47102\/annals-acadmedsg.V39N2p129","volume":"39","author":"WH Chow","year":"2010","unstructured":"Chow WH, Chang P, Lee SC, Wong A, Shen HM, Verkooijen HM (2010) Complementary and alternative medicine among Singapore cancer patients. Ann Acad Med Singap 39(2):129\u2013135","journal-title":"Ann Acad Med Singap"},{"issue":"2","key":"4696_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1055\/s-0030-1252009","volume":"72","author":"F Raimund","year":"2011","unstructured":"Raimund F, Nickel S, Hessler C, Regelsberger J, Westphal M, Heese O (2011) Non-conventional treatments sought by patients after surgery for intramedullary spinal cord tumors. Cent Eur Neurosurg 72(2):71\u201374. https:\/\/doi.org\/10.1055\/s-0030-1252009Epub 2010 May 21. PMID: 20496309","journal-title":"Cent Eur Neurosurg"},{"key":"4696_CR28","doi-asserted-by":"publisher","unstructured":"Magi T, Kuehni CE, Torchetti L, Wengenroth L, L\u00fcer S, Frei-Erb M (2015) Use of Complementary and Alternative Medicine in Children with Cancer: A Study at a Swiss University Hospital. PLoS One. 22;10(12):e0145787. https:\/\/doi.org\/10.1371\/journal.pone.0145787","DOI":"10.1371\/journal.pone.0145787"},{"issue":"1","key":"4696_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11764-010-0153-7","volume":"5","author":"JJ Mao","year":"2011","unstructured":"Mao JJ, Palmer CS, Healy KE, Desai K, Amsterdam J (2011) Complementary and alternative medicine use among cancer survivors: a population-based study. J Cancer Surviv 5(1):8\u201317. https:\/\/doi.org\/10.1007\/s11764-010-0153-7","journal-title":"J Cancer Surviv"},{"issue":"3","key":"4696_CR30","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00432-018-2587-7","volume":"144","author":"R Firkins","year":"2018","unstructured":"Firkins R, Eisfeld H, Keinki C, Buentzel J, Hochhaus A, Schmidt T, Huebner J (2018) The use of complementary and alternative medicine by patients in routine care and the risk of interactions. J Cancer Res Clin Oncol 144(3):551\u2013557. https:\/\/doi.org\/10.1007\/s00432-018-2587-7","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"4696_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jpainsymman.2006.02.015","volume":"32","author":"T Armstrong","year":"2006","unstructured":"Armstrong T, Cohen MZ, Hess KR, Manning R, Lee EL, Tamayo G, Baumgartner K, Min SJ, Yung A, Gilbert M (2006) Complementary and alternative medicine use and quality of life in patients with primary brain tumors. J Pain Symptom Manage 32(2):148\u2013154. https:\/\/doi.org\/10.1016\/j.jpainsymman.2006.02.015","journal-title":"J Pain Symptom Manage"},{"key":"4696_CR32","doi-asserted-by":"publisher","unstructured":"Rudolph I, Seilacher E, K\u00f6ster MJ, Stellamanns J, Liebl P, Zell J, Ludwig S, Beck V, H\u00fcbner J (2015) Der Informationsbedarf von Patienten mit Krebserkrankungen in Deutschland - eine Befragung von Patienten und Angeh\u00f6rigen [Survey on information needs of cancer patients and their relatives in Germany]. Dtsch Med Wochenschr. 140(5):e43-7. German. https:\/\/doi.org\/10.1055\/s-0041-100585","DOI":"10.1055\/s-0041-100585"},{"key":"4696_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1478-7954-5-10","volume":"16","author":"K Eng","year":"2007","unstructured":"Eng K, Feeny D (2007) Comparing the health of low income and less well educated groups in the United States and Canada. Popul Health Metr 16:5:10. https:\/\/doi.org\/10.1186\/1478-7954-5-10","journal-title":"Popul Health Metr"},{"key":"4696_CR34","doi-asserted-by":"publisher","unstructured":"Eidinger RN, Schapira DV (1984) Cancer patients\u2019 insight into their treatment, prognosis, and unconventional therapies. Cancer. 15;53(12):2736-40. https:\/\/doi.org\/10.1002\/1097-0142(19840615)53:12<2736::aid-cncr2820531233>3.0.co;2-w","DOI":"10.1002\/1097-0142(19840615)53:12<2736::aid-cncr2820531233>3.0.co;2-w"},{"key":"4696_CR35","doi-asserted-by":"publisher","unstructured":"King N, Balneaves LG, Levin GT, Nguyen T, Nation JG, Card C, Truant T, Carlson LE (2015) Surveys of Cancer patients and Cancer Health Care Providers regarding complementary therapy Use, Communication, and Information needs. Integr Cancer Ther 6515\u2013524. https:\/\/doi.org\/10.1177\/1534735415589984","DOI":"10.1177\/1534735415589984"},{"issue":"1","key":"4696_CR36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.pec.2009.08.013","volume":"79","author":"GK Halkett","year":"2010","unstructured":"Halkett GK, Lobb EA, Oldham L, Nowak AK (2010) The information and support needs of patients diagnosed with high Grade Glioma. Patient Educ Couns 79(1):112\u2013119. https:\/\/doi.org\/10.1016\/j.pec.2009.08.013","journal-title":"Patient Educ Couns"},{"issue":"1","key":"4696_CR37","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.18295\/squmj.2018.18.01.009","volume":"18","author":"H Al-Lawati","year":"2018","unstructured":"Al-Lawati H, Al-Baimani K, Al-Zadjali M, Al-Obaidani N, Al-Kiyumi Z, Al-Khabori MK (2018) Knowledge and attitudes towards clinical trial participation in Oman: a cross-sectional study. Sultan Qaboos Univ Med J 18(1):e54\u2013e60. https:\/\/doi.org\/10.18295\/squmj.2018.18.01.009","journal-title":"Sultan Qaboos Univ Med J"},{"issue":"2","key":"4696_CR38","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10900-011-9450-y","volume":"37","author":"SF Wallington","year":"2012","unstructured":"Wallington SF, Luta G, Noone AM, Caicedo L, Lopez-Class M, Sheppard V, Spencer C, Mandelblatt J (2012) Assessing the awareness of and willingness to participate in cancer clinical trials among immigrant latinos. J Community Health 37(2):335\u2013343. https:\/\/doi.org\/10.1007\/s10900-011-9450-y","journal-title":"J Community Health"},{"issue":"12","key":"4696_CR39","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1186\/1471-2407-12-594","volume":"12","author":"SJ Lee","year":"2012","unstructured":"Lee SJ, Park LC, Lee J, Kim S, Choi MK, Hong JY, Park S, Maeng CH, Chang W, Kim YS, Park SH, Park JO, Lim HY, Kang WK, Park YS (2012) Unique perception of clinical trials by Korean cancer patients. BMC Cancer 12(12):594. https:\/\/doi.org\/10.1186\/1471-2407-12-594","journal-title":"BMC Cancer"},{"key":"4696_CR40","doi-asserted-by":"publisher","unstructured":"Jenkins V, Farewell D, Batt L, Maughan T, Branston L, Langridge C, Parlour L, Farewell V, Fallowfield L (2010) The attitudes of 1066 patients with cancer towards participation in randomised clinical trials. Br J Cancer. 7;103(12):1801-7. https:\/\/doi.org\/10.1038\/sj.bjc.6606004","DOI":"10.1038\/sj.bjc.6606004"},{"issue":"7","key":"4696_CR41","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00432-015-2099-7","volume":"142","author":"D Ruetters","year":"2015","unstructured":"Ruetters D, Keinki C, Schroth S, Liebl P, Huebner J (2015) Is there evidence for a better health care for cancer patients after a second opinion? A systematic review. J Cancer Res Clin Oncol 142(7):1521\u20131528. https:\/\/doi.org\/10.1007\/s00432-015-2099-7","journal-title":"J Cancer Res Clin Oncol"},{"key":"4696_CR42","doi-asserted-by":"publisher","unstructured":"Fuchs T, Hanaya H, Seilacher E, Koester MJ, Keinki C, Liebl P, Huebner J (2017) Information Deficits and Second Opinion Seeking - A Survey on Cancer Patients. Cancer Invest. 2;35(1):62\u201369. https:\/\/doi.org\/10.1080\/07357907.2016.1242012","DOI":"10.1080\/07357907.2016.1242012"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04696-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-024-04696-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04696-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T14:05:37Z","timestamp":1718805937000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-024-04696-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,6]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["4696"],"URL":"https:\/\/doi.org\/10.1007\/s11060-024-04696-1","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[2024,5,6]]},"assertion":[{"value":"3 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}